Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 7, 2017OncotargetOpen Access

Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast

View Full Paper
Ask AI
Bookmark
Share

Authors

BÓBéla ÓzsváriVancouver Biotech (Canada)MFMarco FiorilloUniversity of CalabriaGBGloria BonuccelliUniversity of Salford

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Ózsvári et al. (2017) studied this question.

synapsesocial.com/papers/6a93b97a80e39a190d56bdcchttps://doi.org/10.18632/oncotarget.19084
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mammalian Mitochondrial Ribosomal Proteins (4)2000 · 84 citations
  2. 2Mitochondrial Evolution1999 · 1,739 citations
  3. 3Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy2015 · 117 citations
  4. 4New Genes Tied to Endocrine, Metabolic, and Dietary Regulation of Lifespan from a Caenorhabditis elegans Genomic RNAi Screen2005 · 557 citations
  5. 5The Dual Origin of the Yeast Mitochondrial Proteome2000 · 176 citations